57% of Voters Believe AI Risks Outweigh the Benefits. What Does That Mean for the OpenAI and Anthropic IPOs?

The article argues that public skepticism toward AI is unlikely to derail OpenAI and Anthropic IPO demand, citing 62% of surveyed investors who expect AI stocks to deliver strong long-term returns. OpenAI recently raised $122 billion at an $852 billion valuation and Anthropic raised $30 billion at a $380 billion valuation, underscoring strong private-market demand ahead of potential listings. It also notes that major tech holdings like Microsoft and Alphabet are increasingly AI-exposed, making many portfolios indirect beneficiaries even for investors wary of direct AI bets.

Analysis

The key market implication is not that AI enthusiasm is broad; it’s that capital is becoming self-reinforcing. As the largest platform and infrastructure names re-rate around AI, passive flows and retirement-account allocation automatically increase exposure to the same theme, which lowers the marginal importance of retail sentiment toward the marquee private names. That makes the eventual IPOs less of a demand test and more of a liquidity event for an already crowded factor complex.

The bigger winner set is the enablement layer, not just the model labs. If OpenAI and Anthropic go public with lofty growth narratives, the market will likely bid the compute, networking, foundry, and hyperscale capex chain before it fully prices the long-dated earnings conversion risk. That favors the semis and infrastructure incumbents, but it also raises the probability of second-order margin pressure as AI capex normalizes and customers push back on pricing once the “must-own” narrative peaks.

The main risk is timing mismatch: IPO excitement can front-load valuation gains while the actual monetization curve remains back-end loaded over years. If public markets start demanding proof of unit economics, model-inference costs, or durable retention, the most exposed names could de-rate quickly even if user adoption remains strong. A second risk is regulatory or antitrust pressure, which would likely hit the largest platform beneficiaries first and compress multiples across the AI complex.

The contrarian read is that skepticism is not bearish enough yet — it has not translated into meaningful underownership of the beneficiaries. In practice, many investors who claim to dislike AI are already long the trade through mega-cap tech, so the real alpha is likely in relative positioning rather than directional exposure. The IPOs may therefore be less about creating a new AI asset class than about crystallizing and redistributing an existing one.

Key Decisions for Investors

• Maintain/ add to NVDA, TSM, and AVGO into any pre-IPO AI enthusiasm over the next 1-3 months; these names should benefit from capital rotation before the market fully prices revenue durability. Best risk/reward is on pullbacks, not breakouts, because the trade is already crowded.
• Pair long MSFT / short a basket of high-duration software names over 3-6 months: MSFT should keep compounding via embedded AI monetization, while weaker software names face multiple compression if investors shift from narrative to cash-flow scrutiny.
• Initiate a tactical long GOOG vs short IWM for 1-2 quarters if AI IPO hype intensifies; mega-cap AI exposure should continue to outcompete the broad market as passive flows and enterprise spend concentrate in proven platforms.
• Avoid chasing direct private-market proxies around hypothetical IPO timing; instead, use listed options on NVDA or AVGO to express upside with defined risk, e.g., 3-6 month call spreads financed by selling higher strikes after any post-runup volatility spike.
• Set a hedge via short-term put spreads on the AI complex if IPO pricing comes at extreme premiums; the best entry would be immediately post-listing, when supply overhang and valuation anchoring can create a 10-20% air pocket in the first 4-8 weeks.